Literature DB >> 34117327

Cholesterol-dependent transcriptome remodeling reveals new insight into the contribution of cholesterol to Mycobacterium tuberculosis pathogenesis.

Jakub Pawełczyk1, Anna Brzostek1, Alina Minias1, Przemysław Płociński1,2, Anna Rumijowska-Galewicz1, Dominik Strapagiel3, Jolanta Zakrzewska-Czerwińska4, Jarosław Dziadek5.   

Abstract

Mycobacterium tuberculosis (Mtb) is an obligate human pathogen that can adapt to the various nutrients available during its life cycle. However, in the nutritionally stringent environment of the macrophage phagolysosome, Mtb relies mainly on cholesterol. In previous studies, we demonstrated that Mtb can accumulate and utilize cholesterol as the sole carbon source. However, a growing body of evidence suggests that a lipid-rich environment may have a much broader impact on the pathogenesis of Mtb infection than previously thought. Therefore, we applied high-resolution transcriptome profiling and the construction of various mutants to explore in detail the global effect of cholesterol on the tubercle bacillus metabolism. The results allow re-establishing the complete list of genes potentially involved in cholesterol breakdown. Moreover, we identified the modulatory effect of vitamin B12 on Mtb transcriptome and the novel function of cobalamin in cholesterol metabolite dissipation which explains the probable role of B12 in Mtb virulence. Finally, we demonstrate that a key role of cholesterol in mycobacterial metabolism is not only providing carbon and energy but involves also a transcriptome remodeling program that helps in developing tolerance to the unfavorable host cell environment far before specific stress-inducing phagosomal signals occur.

Entities:  

Year:  2021        PMID: 34117327     DOI: 10.1038/s41598-021-91812-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  90 in total

1.  Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates.

Authors:  Luiz Pedro S de Carvalho; Steven M Fischer; Joeli Marrero; Carl Nathan; Sabine Ehrt; Kyu Y Rhee
Journal:  Chem Biol       Date:  2010-10-29

2.  Identification of Mycobacterial genes that alter growth and pathology in macrophages and in mice.

Authors:  Jennifer C Chang; Nada S Harik; Reiling P Liao; David R Sherman
Journal:  J Infect Dis       Date:  2007-07-13       Impact factor: 5.226

3.  3-Ketosteroid 9alpha-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Yanmin Hu; Robert van der Geize; Gurdyal S Besra; Sudagar S Gurcha; Alexander Liu; Manfred Rohde; Mahavir Singh; Anthony Coates
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

4.  Mycobacterium tuberculosis is able to accumulate and utilize cholesterol.

Authors:  Anna Brzostek; Jakub Pawelczyk; Anna Rumijowska-Galewicz; Bozena Dziadek; Jaroslaw Dziadek
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

5.  Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains.

Authors:  S Muñoz; B Rivas-Santiago; J A Enciso
Journal:  Scand J Immunol       Date:  2009-09       Impact factor: 3.487

6.  Mycobacterial persistence requires the utilization of host cholesterol.

Authors:  Amit K Pandey; Christopher M Sassetti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

7.  A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol.

Authors:  Natasha M Nesbitt; Xinxin Yang; Patricia Fontán; Irina Kolesnikova; Issar Smith; Nicole S Sampson; Eugenie Dubnau
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

8.  Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment.

Authors:  Brian C VanderVen; Ruth J Fahey; Wonsik Lee; Yancheng Liu; Robert B Abramovitch; Christine Memmott; Adam M Crowe; Lindsay D Eltis; Emanuele Perola; David D Deininger; Tiansheng Wang; Christopher P Locher; David G Russell
Journal:  PLoS Pathog       Date:  2015-02-12       Impact factor: 6.823

9.  The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis.

Authors:  Marta Brzezinska; Izabela Szulc; Anna Brzostek; Magdalena Klink; Michal Kielbik; Zofia Sulowska; Jakub Pawelczyk; Jaroslaw Dziadek
Journal:  BMC Microbiol       Date:  2013-02-20       Impact factor: 3.605

10.  Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence.

Authors:  Pascale Peyron; Julien Vaubourgeix; Yannick Poquet; Florence Levillain; Catherine Botanch; Fabienne Bardou; Mamadou Daffé; Jean-François Emile; Bruno Marchou; Pere-Joan Cardona; Chantal de Chastellier; Frédéric Altare
Journal:  PLoS Pathog       Date:  2008-11-11       Impact factor: 6.823

View more
  2 in total

Review 1.  Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications.

Authors:  Hemant Joshi; Divya Kandari; Rakesh Bhatnagar
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

2.  Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infection.

Authors:  Pallavi Chandra; Héloise Coullon; Mansi Agarwal; Charles W Goss; Jennifer A Philips
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.